藥品參考
Selumetinib
Selumetinib is a medicine in the class oncology.
- 藥物類別: Oncology
最後更新 來源: US FDA label, EMA SmPC
僅供醫療專業人員參考。本頁為簡要摘要，並非醫療建議，亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。
本頁的臨床內容僅提供英文版。
重點資訊
- 藥物類別
- Oncology
- ATC 代碼
- L01EE04
- 常見劑型
- 膠囊
- 常見規格
- 25 mg
- 已知交互作用
- 47 (嚴重: 20 · 中度: 24 · 輕微: 3)
- 商品名
- 3
- 國家與市場
- 3
作用方式
Selumetinib inhibits mitogen-activated protein kinase kinases 1 and 2 (MEK1/2), upstream regulators of the ERK pathway. In NF1 mouse models it inhibited ERK phosphorylation and reduced neurofibroma numbers, volume and proliferation.
成人常用劑量（仿單摘要）
NF1 with symptomatic, inoperable plexiform neurofibromas (capsules): 25 mg/m2 orally twice daily, swallowed whole, with or without food, by body surface area; until disease progression or unacceptable toxicity
懷孕與哺乳
- 懷孕
- Unsafe Can cause fetal harm: in mice it caused embryo death, structural defects and lower fetal weight at over 5 times human exposure. No human data. Check pregnancy status; use effective contraception during and for 1 week after; it may weaken hormonal pills, so add a barrier method.
- 哺乳
- Unsafe No human milk data; it and its active metabolite reach mouse milk. LactMed: 98% protein bound, so milk levels are likely low. Because of possible infant toxicity, do not breastfeed during treatment and for 1 week after the last dose.
已通報的副作用
- Vomiting
- Diarrhea
- Increased creatine phosphokinase
- Dry skin
- Paronychia
- Nausea
禁忌症
- None.
哪些人需要特別留意
- Left ventricular dysfunction: assess ejection fraction before treatment, every 3 months in the first year, then every 6 months.
- Ocular toxicity (RVO, RPED, blurred vision): perform ophthalmic assessments; permanently discontinue for RVO.
- Gastrointestinal toxicity: start anti-diarrheal agent at first loose stool and increase fluids.
請告知藥師或醫師您是否懷孕或哺乳、是否患有腎臟或肝臟疾病、是否有過敏，以及您正在使用的所有其他藥物或保健品。
重要交互作用 (47)
- Amobarbital + Selumetinib Major
- Apalutamide + Selumetinib Major
- Aprepitant + Selumetinib Major
- Carbamazepine + Selumetinib Major
- Chloramphenicol + Selumetinib Major
- Clarithromycin + Selumetinib Major
- Cyclosporin + Selumetinib Major
- Efavirenz + Selumetinib Major
- Enzalutamide + Selumetinib Major
- Fluconazole + Selumetinib Major
Pro+ 會員專屬
解鎖完整頁面
建立帳號並開始 Pro+ 試用，即可開啟 Selumetinib 的完整藥品專論：劑量、懷孕與哺乳、副作用、警示及所有交互作用。
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Paediatric dosing
- How to give it
- Pharmacokinetics
- Patient counselling points
- Food interactions
- IV preparation and dilution
在網頁版免費試用 Pro+ 14 天，無需信用卡。
同類別的其他藥品
常見問題
What is Selumetinib used for?
Selumetinib is a medicine in the class oncology.
What side effects have been reported with Selumetinib?
Vomiting, Diarrhea, Increased creatine phosphokinase, Dry skin, Paronychia, Nausea.
Can Selumetinib be taken in pregnancy or while breastfeeding?
Pregnancy: Unsafe. Can cause fetal harm: in mice it caused embryo death, structural defects and lower fetal weight at over 5 times human exposure. No human data. Check pregnancy status; use effective contraception during and for 1 week after; it may weaken hormonal pills, so add a barrier method. Breastfeeding: Unsafe. No human milk data; it and its active metabolite reach mouse milk. LactMed: 98% protein bound, so milk levels are likely low. Because of possible infant toxicity, do not breastfeed during treatment and for 1 week after the last dose.
What does Selumetinib interact with?
MediHelp lists 47 known interactions for Selumetinib. Major: 20 · Moderate: 24 · Minor: 3. The most serious include Amobarbital, Apalutamide, Aprepitant.
在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查
在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用，並使用劑量工具。
